Report Detail

Pharma & Healthcare Global Pemetrexed Drug Market Growth (Status and Outlook) 2019-2024

  • RnM2815924
  • |
  • 25 January, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.

According to this study, over the next five years the Pemetrexed Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Pemetrexed Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Pemetrexed Drug market by product type, application, key companies and key regions.

This study considers the Pemetrexed Drug value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
100 mg lyophilized powder/vial
500 mg lyophilized powder/vial
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Pleural mesothelioma
Non-small cell lung cancer

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Eli Lilly and Company
Pfizer
Teva
Eagle Pharmaceuticals
APOTEX
Qilu Pharmaceutical
Biocon
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pemetrexed Drug market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pemetrexed Drug market by identifying its various subsegments.
Focuses on the key global Pemetrexed Drug players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pemetrexed Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Pemetrexed Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Pemetrexed Drug Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Pemetrexed Drug Market Size 2014-2024
        • 2.1.2 Pemetrexed Drug Market Size CAGR by Region
      • 2.2 Pemetrexed Drug Segment by Type
        • 2.2.1 100 mg lyophilized powder/vial
        • 2.2.2 500 mg lyophilized powder/vial
      • 2.3 Pemetrexed Drug Market Size by Type
        • 2.3.1 Global Pemetrexed Drug Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Pemetrexed Drug Market Size Growth Rate by Type (2014-2019)
      • 2.4 Pemetrexed Drug Segment by Application
        • 2.4.1 Pleural mesothelioma
        • 2.4.2 Non-small cell lung cancer
      • 2.5 Pemetrexed Drug Market Size by Application
        • 2.5.1 Global Pemetrexed Drug Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Pemetrexed Drug Market Size Growth Rate by Application (2014-2019)

      3 Global Pemetrexed Drug by Players

      • 3.1 Global Pemetrexed Drug Market Size Market Share by Players
        • 3.1.1 Global Pemetrexed Drug Market Size by Players (2017-2019)
        • 3.1.2 Global Pemetrexed Drug Market Size Market Share by Players (2017-2019)
      • 3.2 Global Pemetrexed Drug Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Pemetrexed Drug by Regions

      • 4.1 Pemetrexed Drug Market Size by Regions
      • 4.2 Americas Pemetrexed Drug Market Size Growth
      • 4.3 APAC Pemetrexed Drug Market Size Growth
      • 4.4 Europe Pemetrexed Drug Market Size Growth
      • 4.5 Middle East & Africa Pemetrexed Drug Market Size Growth

      5 Americas

      • 5.1 Americas Pemetrexed Drug Market Size by Countries
      • 5.2 Americas Pemetrexed Drug Market Size by Type
      • 5.3 Americas Pemetrexed Drug Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Pemetrexed Drug Market Size by Countries
      • 6.2 APAC Pemetrexed Drug Market Size by Type
      • 6.3 APAC Pemetrexed Drug Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Pemetrexed Drug by Countries
      • 7.2 Europe Pemetrexed Drug Market Size by Type
      • 7.3 Europe Pemetrexed Drug Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Pemetrexed Drug by Countries
      • 8.2 Middle East & Africa Pemetrexed Drug Market Size by Type
      • 8.3 Middle East & Africa Pemetrexed Drug Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Pemetrexed Drug Market Forecast

      • 10.1 Global Pemetrexed Drug Market Size Forecast (2019-2024)
      • 10.2 Global Pemetrexed Drug Forecast by Regions
        • 10.2.1 Global Pemetrexed Drug Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Pemetrexed Drug Forecast by Type
      • 10.8 Global Pemetrexed Drug Forecast by Application

      11 Key Players Analysis

      • 11.1 Eli Lilly and Company
        • 11.1.1 Company Details
        • 11.1.2 Pemetrexed Drug Product Offered
        • 11.1.3 Eli Lilly and Company Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Eli Lilly and Company News
      • 11.2 Pfizer
        • 11.2.1 Company Details
        • 11.2.2 Pemetrexed Drug Product Offered
        • 11.2.3 Pfizer Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Pfizer News
      • 11.3 Teva
        • 11.3.1 Company Details
        • 11.3.2 Pemetrexed Drug Product Offered
        • 11.3.3 Teva Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Teva News
      • 11.4 Eagle Pharmaceuticals
        • 11.4.1 Company Details
        • 11.4.2 Pemetrexed Drug Product Offered
        • 11.4.3 Eagle Pharmaceuticals Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Eagle Pharmaceuticals News
      • 11.5 APOTEX
        • 11.5.1 Company Details
        • 11.5.2 Pemetrexed Drug Product Offered
        • 11.5.3 APOTEX Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 APOTEX News
      • 11.6 Qilu Pharmaceutical
        • 11.6.1 Company Details
        • 11.6.2 Pemetrexed Drug Product Offered
        • 11.6.3 Qilu Pharmaceutical Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Qilu Pharmaceutical News
      • 11.7 Biocon
        • 11.7.1 Company Details
        • 11.7.2 Pemetrexed Drug Product Offered
        • 11.7.3 Biocon Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Biocon News

      ...

        12 Research Findings and Conclusion

        Summary:
        Get latest Market Research Reports on Pemetrexed Drug . Industry analysis & Market Report on Pemetrexed Drug is a syndicated market report, published as Global Pemetrexed Drug Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Pemetrexed Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,660.00
        $5,490.00
        $7,320.00
        2,898.72
        4,348.08
        5,797.44
        3,381.84
        5,072.76
        6,763.68
        553,721.40
        830,582.10
        1,107,442.80
        305,134.20
        457,701.30
        610,268.40
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report